Table 5 APOE rs439401 polymorphism and cardiometabolic risk

T2D

C/T

Control

Case

CT vs CC:

1.57 [0.88–2.79]

p = 0.13

TT vs CC:

2.12 [1.02–4.39]

p = 0.04

1.47 [1.03–2.09]

p = 0.03

CC (254)

CT (285)

TT (95)

CC (22)

CT (38)

TT (16)

Obesity

C/T

CC (233)

CT (262)

TT (89)

CC (57)

CT (74)

TT (26)

CA vs CC:

1.27 [0.84–1.92]

p = 0.26

AA vs CC:

1.34 [0.76–2.35]

p = 0.31

1.16 [0.89–1.51]

p = 0.27

MetS

C/T

CC (228)

CT (265)

TT (90)

CC (56)

CT (65)

TT (24)

AT vs AA:

1.04 [0.68–1.59]

p = 0.87

TT vs AA:

1.13 [0.64–2.02]

p = 0.67

1.06 [0.80–1.40]

p = 0.69

HBP

C/T

CC (241)

CT (262)

TT (86)

CC (49)

CT (74)

TT (29)

CT vs CC:

1.46 [0.95–2.26]

p = 0.09

TT vs CC:

1.90 [1.07–3.36]

p = 0.03

1.46 [1.12–1.90]

p = 0.006*